Mammalian cell enumeration assay expands range of adenylate kinase (AK) kits for detection and enumeration of gram negative bacteria
Following the successful launch of the BacLite Rapitect GN kit for the detection and enumeration of gram negative bacteria, Acolyte Biomedica is expanding the range to include a mammalian cell enumeration assay.
The BacLite Rapitect M uses the Acolyte Biomedica AK Rapid technology and will provide a rapid and highly sensitive method to enumerate mammalian cells, says the company.
The new product will replace the laborious techniques currently used to quantify cells and optimise cell culture conditions.
The development is being undertaken in collaboration with Barbara Reaves, an expert in the field of molecular and cellular biology from the University of Bath, UK.
The BacLite Rapitect M assay will use adenylate kinase (AK) as a highly sensitive marker to measure mammalian cell numbers.
This method offers advantages over standard manual cell counting techniques by using high sensitivity and a wide dynamic range to give precise and objective results.
Sarah Gregory of Acolyte Biomedica, who is involved in the development programme, said: "The Rapitect M assay is designed to work on all mammalian cell types.
"It has important applications in cell culturing and cell harvesting, whether in institutional research or for the production of biomolecules for commercial use".
The mammalian cell assay will be available early 2006.
